Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bayer halts midstage riociguat study after serious safety concerns
Bayer halts midstage riociguat study after serious safety concerns
Bayer halts midstage riociguat study after serious safety concerns
Submitted by
admin
on May 12, 2016 - 4:58pm
Source:
Fierce Biotech
News Tags:
Bayer
Riociguat
clinical trials
pulmonary hypertension
Headline:
Bayer halts midstage riociguat study after serious safety concerns
Do Not Allow Advertisers to Use My Personal information
